Literature DB >> 31250346

Mathematical Modeling of the Metastatic Colorectal Cancer Microenvironment Defines the Importance of Cytotoxic Lymphocyte Infiltration and Presence of PD-L1 on Antigen Presenting Cells.

Jenny Lazarus1, Morgan D Oneka2, Souptik Barua2, Tomasz Maj1, Mirna Perusina Lanfranca1, Lawrence Delrosario1, Lei Sun1, J Joshua Smith3, Michael I D'Angelica3, Jinru Shia4, Jiayun M Fang5, Jiaqi Shi5, Marina Pasca Di Magliano1, Weiping Zou1, Arvind Rao6,2,7, Timothy L Frankel8.   

Abstract

BACKGROUND: Although immune-based therapy has proven efficacious for some patients with microsatellite instability (MSI) colon cancers, a majority of patients receive limited benefit. Conversely, select patients with microsatellite stable (MSS) tumors respond to checkpoint blockade, necessitating novel ways to study the immune tumor microenvironment (TME). We used phenotypic and spatial data from infiltrating immune and tumor cells to model cellular mixing to predict disease specific outcomes in patients with colorectal liver metastases.
METHODS: Formalin fixed paraffin embedded metastatic colon cancer tissue from 195 patients were subjected to multiplex immunohistochemistry (mfIHC). After phenotyping, the G-function was calculated for each patient and cell type. Data was correlated with clinical outcomes and survival.
RESULTS: High tumor cell to cytotoxic T lymphocyte (TC-CTL) mixing was associated with both a pro-inflammatory and immunosuppressive TME characterized by increased CTL infiltration and PD-L1+ expression, respectively. Presence and engagement of antigen presenting cells (APC) and helper T cells (Th) were associated with greater TC-CTL mixing and improved 5-year disease specific survival compared to patients with a low degree of mixing (42% vs. 16%, p = 0.0275). Comparison of measured mixing to a calculated theoretical random mixing revealed that PD-L1 expression on APCs resulted in an environment where CTLs were non-randomly less associated with TCs, highlighting their biologic significance.
CONCLUSION: Evaluation of immune interactions within the TME of metastatic colon cancer using mfIHC in combination with mathematical modeling characterized cellular mixing of TCs and CTLs, providing a novel strategy to better predict clinical outcomes while identifying potential candidates for immune based therapies.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31250346      PMCID: PMC6684475          DOI: 10.1245/s10434-019-07508-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   4.339


  26 in total

1.  Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis.

Authors:  M Guidoboni; R Gafà; A Viel; C Doglioni; A Russo; A Santini; L Del Tin; E Macrì; G Lanza; M Boiocchi; R Dolcetti
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases.

Authors:  Steven C Katz; Venu Pillarisetty; Zubin M Bamboat; Jinru Shia; Cyrus Hedvat; Mithat Gonen; William Jarnagin; Yuman Fong; Leslie Blumgart; Michael D'Angelica; Ronald P DeMatteo
Journal:  Ann Surg Oncol       Date:  2009-07-01       Impact factor: 5.344

3.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.

Authors:  Y Fong; J Fortner; R L Sun; M F Brennan; L H Blumgart
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

4.  Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

Authors:  Tyler J Curiel; Shuang Wei; Haidong Dong; Xavier Alvarez; Pui Cheng; Peter Mottram; Roman Krzysiek; Keith L Knutson; Ben Daniel; Maria Carla Zimmermann; Odile David; Matthew Burow; Alan Gordon; Nina Dhurandhar; Leann Myers; Ruth Berggren; Akseli Hemminki; Ronald D Alvarez; Dominique Emilie; David T Curiel; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2003-04-21       Impact factor: 53.440

5.  Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.

Authors:  Jérôme Galon; Anne Costes; Fatima Sanchez-Cabo; Amos Kirilovsky; Bernhard Mlecnik; Christine Lagorce-Pagès; Marie Tosolini; Matthieu Camus; Anne Berger; Philippe Wind; Franck Zinzindohoué; Patrick Bruneval; Paul-Henri Cugnenc; Zlatko Trajanoski; Wolf-Herman Fridman; Franck Pagès
Journal:  Science       Date:  2006-09-29       Impact factor: 47.728

6.  Prognostic role of CD8+ tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability.

Authors:  Friedrich Prall; Thomas Dührkop; Volker Weirich; Christiane Ostwald; Peter Lenz; Horst Nizze; Malte Barten
Journal:  Hum Pathol       Date:  2004-07       Impact factor: 3.466

7.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Authors:  Tyler J Curiel; George Coukos; Linhua Zou; Xavier Alvarez; Pui Cheng; Peter Mottram; Melina Evdemon-Hogan; Jose R Conejo-Garcia; Lin Zhang; Matthew Burow; Yun Zhu; Shuang Wei; Ilona Kryczek; Ben Daniel; Alan Gordon; Leann Myers; Andrew Lackner; Mary L Disis; Keith L Knutson; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

8.  Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

Authors:  Thierry André; Corrado Boni; Lamia Mounedji-Boudiaf; Matilde Navarro; Josep Tabernero; Tamas Hickish; Clare Topham; Marta Zaninelli; Philip Clingan; John Bridgewater; Isabelle Tabah-Fisch; Aimery de Gramont
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

9.  Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers.

Authors:  Yvette Schwitalle; Matthias Kloor; Susanne Eiermann; Michael Linnebacher; Peter Kienle; Hanns Peter Knaebel; Mirjam Tariverdian; Axel Benner; Magnus von Knebel Doeberitz
Journal:  Gastroenterology       Date:  2008-01-11       Impact factor: 22.682

10.  Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic.

Authors:  S M Phillips; A Banerjea; R Feakins; S R Li; S A Bustin; S Dorudi
Journal:  Br J Surg       Date:  2004-04       Impact factor: 6.939

View more
  8 in total

1.  Identification and validation of prognosis-associated DNA repair gene signatures in colorectal cancer.

Authors:  Dingli Song; Dai Zhang; Sisi Chen; Jie Wu; Qian Hao; Lili Zhao; Hong Ren; Ning Du
Journal:  Sci Rep       Date:  2022-04-28       Impact factor: 4.996

2.  Cellular engagement and interaction in the tumor microenvironment predict non-response to PD-1/PD-L1 inhibitors in metastatic non-small cell lung cancer.

Authors:  Angel Qin; Fatima Lima; Samantha Bell; Gregory P Kalemkerian; Bryan J Schneider; Nithya Ramnath; Madelyn Lew; Santhoshi Krishnan; Shariq Mohammed; Arvind Rao; Timothy L Frankel
Journal:  Sci Rep       Date:  2022-05-31       Impact factor: 4.996

Review 3.  Current and Prospective Methods for Assessing Anti-Tumor Immunity in Colorectal Cancer.

Authors:  Yulia I Nussbaum; Yariswamy Manjunath; Kanve N Suvilesh; Wesley C Warren; Chi-Ren Shyu; Jussuf T Kaifi; Matthew A Ciorba; Jonathan B Mitchem
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

4.  Prognostic significance of spatial and density analysis of T lymphocytes in colorectal cancer.

Authors:  Hanna Elomaa; Maarit Ahtiainen; Sara A Väyrynen; Shuji Ogino; Jonathan A Nowak; Marjukka Friman; Olli Helminen; Erkki-Ville Wirta; Toni T Seppälä; Jan Böhm; Markus J Mäkinen; Jukka-Pekka Mecklin; Teijo Kuopio; Juha P Väyrynen
Journal:  Br J Cancer       Date:  2022-04-21       Impact factor: 9.075

5.  MHC Class II Expression Influences the Composition and Distribution of Immune Cells in the Metastatic Colorectal Cancer Microenvironment.

Authors:  Brian D Griffith; Simon Turcotte; Jenny Lazarus; Fatima Lima; Samantha Bell; Lawrence Delrosario; Jake McGue; Santhoshi Krishnan; Morgan D Oneka; Hari Nathan; J Joshua Smith; Michael I D'Angelica; Jinru Shia; Marina Pasca Di Magliano; Arvind Rao; Timothy L Frankel
Journal:  Cancers (Basel)       Date:  2022-08-24       Impact factor: 6.575

6.  Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis.

Authors:  Diederik J Höppener; Pieter M H Nierop; Joost Hof; Kostandinos Sideras; Guoying Zhou; Lydia Visser; Annette S H Gouw; Koert P de Jong; Dave Sprengers; Jaap Kwekkeboom; Peter B Vermeulen; Dirk J Grünhagen; Cornelis Verhoef
Journal:  Br J Cancer       Date:  2020-05-18       Impact factor: 7.640

7.  Establishment of prognostic nomogram for elderly colorectal cancer patients: a SEER database analysis.

Authors:  Chaoran Yu; Yujie Zhang
Journal:  BMC Gastroenterol       Date:  2020-10-20       Impact factor: 3.067

8.  IRF1-mediated immune cell infiltration is associated with metastasis in colon adenocarcinoma.

Authors:  Yao-Jian Shao; Jun-Jie Ni; Shen-Yu Wei; Xiong-Peng Weng; Meng-Die Shen; Yi-Xin Jia; Li-Na Meng
Journal:  Medicine (Baltimore)       Date:  2020-09-11       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.